Maintenance of long-term remission using oral administration of low-dose etoposide in a patient demonstrating a relapse of blastic natural killer-cell lymphoma [2]

Clinical and Experimental Dermatology

Volumn 32, Issue 1, 2007, Pages 96-97

  Hatano, Y ^a   Ogata, M ^a   Ohishi, M ^a   Anan, T ^a   Senba, K ^a   Yasumatsu, T ^a   Katagiri, K ^a   Kashima, K ^a   Yokoyama, S ^a   Kadota, J I ^a   Takayasu, S ^b   Fujiwara, S ^a  

^a OITA UNIVERSITY   (Japan)

^b Oita Oka Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD56 ANTIGEN; CYCLOPHOSPHAMIDE; DNA NUCLEOTIDYLEXOTRANSFERASE; ETOPOSIDE; LEUKOSIALIN; PIRARUBICIN; PREDNISOLONE; VINCRISTINE;

AGED; CASE REPORT; CELL PROLIFERATION; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LETTER; LEUKOCYTE COUNT; LOW DRUG DOSE; LYMPHOCYTIC INFILTRATION; LYMPHOMA CELL; MAINTENANCE THERAPY; MALE; MITOSIS; MULTIPLE CYCLE TREATMENT; NATURAL KILLER CELL; PLAQUE FORMING CELL; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL TIME; THROMBOCYTE COUNT; TUMOR BIOPSY;

ADMINISTRATION, ORAL; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOPSY; ETOPOSIDE; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL, CUTANEOUS; MALE; RECURRENCE; REMISSION INDUCTION; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 33845802109     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02227.x     Document Type: Letter

References (4)

1. Petrella T, Bagot M, Willemze R et al. Blastic NK-cell lymphoma (agranular CD4+ CD56+ hematodermic neoplasms). Am J Clin Pathol 2005; 123: 662-75.
2. Sakoda H, Yoshida H, Usami M et al. Chronic daily oral low-dose etoposide therapy for an aged patient with aggressive lymphoma: a successful case report. Gan Kagaku Ryoho 1993; 20: 1079-82.
3. Niitsu N, Umeda M. Evaluation of long-term daily administration of oral low-dose etoposide in elderly patients with relapsing or refractory non- Hodgkin's lymphoma. Am J Clin Oncol 1997; 20: 311-14.
4. Onozuka T, Yokota K, Kawashima T et al. An elderly patient with mycosis fungoides successfully treated with chronic low-dose oral etoposide therapy. Clin Exp Dermatol 2004; 29: 91-2.